Clinical Trial Update: AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 study evaluating autologous hematopoietic stem cell transplantation with fludarabine and cyclophosphamide conditioning in patients with Multiple Scleros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Multiple Sclerosis | Phase 1 | Status: RECRUITING